Reeses Tabtussin
Product Images NDC 10956-161

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Reeses Tabtussin (NDC 10956-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reese Pharmaceutical Co, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (Carton)

Reeses TABtussin DM tablet packaging label showing a box design with active ingredients guaifenesin 400 mg and dextromethorphan HBr 20 mg. The label highlights expectorant and cough suppressant functions, immediate release format with 24 tablets per package. Manufacturer identified as Reese Pharmaceutical Company. The label also includes warnings, directions, and inactive ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.